First Trust Nasdaq Pharmaceu ETF (FTXH): which funds own it
A 13F shows the portfolio at quarter-end and is filed up to 45 days later: these are not real-time positions and they may have changed.
Sections with a free account
No concentrated manager holds it.
Quarter flow (concentrated managers)
Concentrated managers holding it
None in the latest quarter.
Largest holders of FTXH (all 13F filers)
- LPL Financial151 KWealth adviser−26 K
- Oppenheimer114 KType not verified+74 K
- Raymond James Financial55 KWealth adviser+43 K
- Truist Financial52 KBank or trading desk−4,962
- Marshall Investment Management38 KType not verified−7,152
- Ameritas Investment Partners34 KType not verified+3,922
- Cambridge Investment Research Advisors31 KWealth adviser+11 K
- Nilsine Partners28 KType not verified+937
- Royal Bank of Canada14 KBank or trading desk+14 K
- Goldman Sachs Group14 KBank or trading desk−5,624
- Shares
- 151 K
- Change
- −26 K
See more
- Type
- Wealth adviser
- Value
- $5.8M
- Shares
- 114 K
- Change
- +74 K
See more
- Type
- Type not verified
- Value
- $4.4M
- Shares
- 55 K
- Change
- +43 K
See more
- Type
- Wealth adviser
- Value
- $2.1M
- Shares
- 52 K
- Change
- −4,962
See more
- Type
- Bank or trading desk
- Value
- $2.0M
- Marshall Investment Management
- Shares
- 38 K
- Change
- −7,152
See more
- Type
- Type not verified
- Value
- $1.5M
- Shares
- 34 K
- Change
- +3,922
See more
- Type
- Type not verified
- Value
- $1.3M
- Shares
- 31 K
- Change
- +11 K
See more
- Type
- Wealth adviser
- Value
- $1.2M
- Shares
- 28 K
- Change
- +937
See more
- Type
- Type not verified
- Value
- $1.1M
- Shares
- 14 K
- Change
- +14 K
See more
- Type
- Bank or trading desk
- Value
- $547K
- Shares
- 14 K
- Change
- −5,624
See more
- Type
- Bank or trading desk
- Value
- $524K
The 10 13F filers with the most shares as of Jun 30, 2026, whatever their type (index firms usually come first). “Change”: shares added or cut versus the previous quarter, split-adjusted; “no data” = there is no comparable portfolio for the previous quarter (no filing, or a filing with its holdings under confidential treatment). “% of the company” only where shares outstanding are up to date. Entities of the same group file separately and some 13F filings include other managers: there may be double counting. With a free account: the top 25, the largest buyers and the largest sellers.
Insiders (Form 4)
Open-market purchases, excluding 10b5-1 plans. Officers and directors only; joint filers of the same purchase count as one. 10% owners with no role are shown separately. 0 = nobody bought; “no data” = we do not have its Form 4 filings.
Each of the company's Form 4 filings, on EDGAR ↗Latest trades, with date and filing →
Above 5% (13D/13G)
Disclosed stakes, with their amendments. A filing is not always a purchase: there are also reductions and changes of filing entity.
This list may be incomplete: we hold 13D and 13G filings made since Dec 23, 2024. A holder above 5% that has not filed anything since then is not shown here.
- First Trust Portfolios74.52%13G · amendmentfiling ↗Event: Sep 30, 2026 · filed: Oct 27, 2026
- Truist Financial0.2%(fell below 5%)13G · amendmentfiling ↗Event: Sep 30, 2026 · filed: Oct 19, 2026
- First Trust Portfolios76.61%13G · amendmentfiling ↗Event: Aug 31, 2026 · filed: Sep 4, 2026
Above 5% over time (13D/13G)
Each holder with its filings in order. History since December 2024.
This company filed no 8-K forms in the last year. Foreign companies listed in the US (ADRs) report material events on forms 6-K and 20-F, and ETFs and funds do not file 8-Ks. If it is a foreign company listed in the US through ADRs (American Depositary Receipts), what trades are bank-issued certificates that represent shares from its home market. See its filings on EDGAR ↗